Literature DB >> 35622217

Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet's disease.

Fatih Celik1, Ebru Coteli2, Fatih Cem Gul1, Ercan Ozsoy3, Sabiha Gungor Kobat1, Zuhal Karaca Karagoz4, Suna Aydin5,6, Kader Ugur7, Meltem Yardim8, İbrahim Sahin9,10, Mehmet Hanifi Yalcin11, Ramazan Fazil Akkoc6, Suleyman Aydin12.   

Abstract

PURPOSE: The molecules human interleukin (IL-18), the soluble cluster of differentiation (sCD40), platelet factor 4 variant 1 (PF4V1), and neutrophil gelatinase-associated lipocalin (NGAL) are all markers of inflammation in biological systems and are linked to prognosis in several inflammatory diseases as well. Since there is no study in which the above-mentioned molecules are studied together in ocular Behçet's disease (OBD), the aim of this study is to reveal whether these molecules are activity markers in active (OABD) and inactive (OIBD) disease.
METHODS: 30 OABD and 30 OIBD and 30 healthy individuals were included in the study. IL-18, sCD40, PF4V1, and NGAL molecules were studied in blood samples by the ELISA method.
RESULTS: When OABD and OIBD were compared to healthy individuals, the levels of IL-18, sCD40, PF4V1, and NGAL molecules were found to be statistically significant. These values were even more significantly higher in patients with OABD.
CONCLUSION: When ROC values of IL-18, sCD40, PF4V1, and NGAL are evaluated, it is clear that these four molecules can be used as biomarkers to aid activity and diagnosis in OBD.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Interleukin; Neutrophil gelatinase-associated lipocalin; Ocular Behçet’s disease; Platelet factor; Soluble cluster of differentiation

Year:  2022        PMID: 35622217     DOI: 10.1007/s10792-022-02331-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  41 in total

Review 1.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

2.  Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?

Authors:  U Musabak; S Pay; H Erdem; I Simsek; A Pekel; A Dinc; A Sengul
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

Review 3.  Current approach in the diagnosis and management of panuveitis.

Authors:  Reema Bansal; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

4.  Turkish scientist Hulusi Behçet (1889-1948) and his contribution to the medical world.

Authors:  Yaşar B Turgut; Mehmet Turgut
Journal:  Childs Nerv Syst       Date:  2019-02-20       Impact factor: 1.475

Review 5.  Behçet's syndrome pathophysiology and potential therapeutic targets.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Mario Milco D'Elios; Lucia Ciucciarelli; Domenico Prisco; Lorenzo Emmi
Journal:  Intern Emerg Med       Date:  2014-01-12       Impact factor: 3.397

6.  Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.

Authors:  M O Oztas; M Onder; M A Gurer; N Bukan; B Sancak
Journal:  Clin Exp Dermatol       Date:  2005-01       Impact factor: 3.470

7.  Serum Cortistatin Levels in Patients with Ocular Active and Ocular Inactive Behçet Disease.

Authors:  Mehmet Balbaba; Fatih Ulaş; Sevinç Arzu Postacı; Burak Öz; Süleyman Aydın
Journal:  Ocul Immunol Inflamm       Date:  2019-07-17       Impact factor: 3.070

Review 8.  CD40/CD40 ligand interactions in immune responses and pulmonary immunity.

Authors:  Tsutomu Kawabe; Miyoko Matsushima; Naozumi Hashimoto; Kazuyoshi Imaizumi; Yoshinori Hasegawa
Journal:  Nagoya J Med Sci       Date:  2011-08       Impact factor: 1.131

Review 9.  Immunopathogenesis of Behcet's Disease.

Authors:  Bainan Tong; Xiaoli Liu; Jun Xiao; Guanfang Su
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

Review 10.  The Regulation of Inflammation by Innate and Adaptive Lymphocytes.

Authors:  David Alex Cronkite; Tara M Strutt
Journal:  J Immunol Res       Date:  2018-06-11       Impact factor: 4.818

View more
  1 in total

Review 1.  Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment.

Authors:  Stella Amarachi Ihim; Sharafudeen Dahiru Abubakar; Zeineb Zian; Takanori Sasaki; Mohammad Saffarioun; Shayan Maleknia; Gholamreza Azizi
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.